Accendra Health, Inc. (NYSE:ACH) shares surged nearly 10% in premarket trading on Monday after the home-based healthcare company reported first-quarter 2026 earnings that came in ahead of analyst expectations.
The company posted an adjusted loss of $0.04 per share for the quarter ended March 31, 2026, outperforming consensus forecasts for a loss of $0.10 per share.
Revenue Misses Expectations Amid Ongoing Transformation
Quarterly revenue totaled $627.8 million, below analyst expectations of $646.24 million and down 6.8% from $673.9 million in the same period last year.
On a GAAP basis, Accendra reported a loss from continuing operations of $0.08 per share, compared with a loss of $0.05 per share in the first quarter of 2025.
Adjusted EBITDA declined to $58.4 million from $96.0 million in the prior-year quarter.
“Our first quarter results were aligned with our expectations as we continue our transformation into a pure play home based care company,” said President and Chief Executive Officer Edward A. Pesicka. “We are also pleased to report that transition services and other separation activity related to our divestiture of Owens & Minor are on track and going according to schedule.”
Company Announces Major Balance Sheet Optimization Plan
Accendra also revealed that it has secured commitments from existing creditors for a balance sheet optimization transaction valued at more than $1.5 billion.
According to the company, the refinancing initiative is expected to strengthen its financial position, extend debt maturities and lower overall leverage.
The transaction includes plans to repay debt maturing in 2027 and extend the company’s revolving credit facility.
Full-Year Guidance Reaffirmed
Despite the revenue shortfall, Accendra maintained its previously issued full-year 2026 guidance for both net revenue and adjusted EBITDA.